ANGO AngioDynamics, Inc.
Healthcare$11.86+0.00%OpenMarket Cap: $490.0M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
2.86
P/S
1.57
EV/EBITDA
-116.95
DCF Value
$2.71
FCF Yield
0.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
53.5%
Operating Margin
-8.1%
Net Margin
-10.0%
ROE
-17.6%
ROA
-12.0%
ROIC
-13.0%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q3 null | $78.4M | 52.9% | $-6.4M | $-8.1M | $— | — |
| Q2 null | $79.4M | 53.1% | $-2.5M | $-6.3M | $— | — |
| Q1 null | $75.7M | 55.3% | $-10.7M | $-10.9M | $— | — |
| Q4 null | $80.2M | 52.7% | $-5.8M | $-6.0M | $— | — |
| FY null | $292.5M | 53.9% | $-40.0M | $-34.0M | $— | — |
| Q3 null | $72.0M | 54.0% | $-10.0M | $-4.4M | $— | — |
| Q2 null | $72.8M | 54.8% | $-11.1M | $-10.7M | $— | — |
| Q1 null | $67.5M | 54.4% | $-13.1M | $-12.8M | $— | — |
| Q4 null | $71.0M | 54.3% | $-14.4M | $-13.4M | $— | — |
| FY null | $303.9M | 50.9% | $-192.4M | $-184.3M | $— | — |
| Q3 2024 | $75.2M | 47.7% | $-199.9M | $-187.7M | $-4.67 | — |
| Q2 2024 | $79.1M | 50.9% | $-13.1M | $-29.0M | $-0.72 | — |